CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 22 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $219,000 | -5.6% | 32,213 | +2.7% | 0.00% | – |
| Q3 2016 | $232,000 | +1.8% | 31,373 | +12.7% | 0.00% | – |
| Q2 2016 | $228,000 | +570.6% | 27,833 | +393.1% | 0.00% | – |
| Q1 2016 | $34,000 | +9.7% | 5,645 | -1.9% | 0.00% | – |
| Q4 2015 | $31,000 | +63.2% | 5,754 | +23.4% | 0.00% | – |
| Q3 2015 | $19,000 | -20.8% | 4,661 | -2.6% | 0.00% | – |
| Q2 2015 | $24,000 | +41.2% | 4,787 | +13.8% | 0.00% | – |
| Q1 2015 | $17,000 | -5.6% | 4,205 | -6.4% | 0.00% | – |
| Q4 2014 | $18,000 | +12.5% | 4,493 | +7.8% | 0.00% | – |
| Q3 2014 | $16,000 | +6.7% | 4,169 | -6.8% | 0.00% | – |
| Q2 2014 | $15,000 | 0.0% | 4,475 | +2.9% | 0.00% | – |
| Q1 2014 | $15,000 | +15.4% | 4,347 | +13.8% | 0.00% | – |
| Q4 2013 | $13,000 | 0.0% | 3,819 | +4.4% | 0.00% | – |
| Q3 2013 | $13,000 | -23.5% | 3,659 | +8.5% | 0.00% | – |
| Q2 2013 | $17,000 | – | 3,371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |